SWM
ALBO

Sugarloaf Wealth Management’s Albireo Pharma Inc ALBO Stock Holding History

Sugarloaf Wealth Management’s Portfolio ALBO Stock Details ALBO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-10
Closed – – 798
2020
Q4 		$0 Hold
10
– – ﹤0.01% 763
2020
Q3 		$0 Sell
10
-1
-9% -$29 ﹤0.01% 738
2020
Q2 		$0 Hold
11
– – ﹤0.01% 743
2020
Q1 		$0 Hold
11
– – ﹤0.01% 756
2019
Q4 		$0 Buy
+11
New +$220 ﹤0.01% 717

Other funds holding ALBO

Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
CC
Chicago Capital Chicago, Illinois $3.71B AUM 19.51% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
RHJA
Rice Hall James & Associates San Diego, California $1.8B AUM 36.16% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return

Sugarloaf Wealth Management's ALBO Position: Q1 2021 in Review

Sugarloaf Wealth Management sold out of Albireo Pharma Inc (ALBO) in Q1 2021, closing a stake of 10 shares.

Sugarloaf Wealth Management first reported a position in ALBO in Q4 2019 and held it in 5 quarters. The position peaked at $0 in Q4 2020. 100 funds tracked by Wall St. Rank hold ALBO as of Q1 2021.

  • Sugarloaf Wealth Management reported no remaining Albireo Pharma Inc position as of Q1 2021 after selling out during the quarter.
  • Sugarloaf Wealth Management sold 10 Albireo Pharma Inc shares in Q1 2021.
  • Sugarloaf Wealth Management first reported a position in Albireo Pharma Inc in Q4 2019 and held it in 5 quarters.
  • Sugarloaf Wealth Management's Albireo Pharma Inc position peaked at $0 in Q4 2020.
  • 100 funds tracked by Wall St. Rank held Albireo Pharma Inc as of Q1 2021.

Based on Sugarloaf Wealth Management's 13F filing for Q1 2021, filed 19 Apr 2021.